NCT05546138
Characterization and Prediction of Early Onset Diabetic Peripheral Neuropathy
Recruiting · Not specified · Aalborg University Hospital · registry updated 2024-06-28
Inclusion and exclusion lines below are quoted from ClinicalTrials.gov. No match score is shown, because a score needs a person's age, biomarkers, and treatment dates. Confirm the record with the study team.
Predicting early onset neuropathy in people with type 1 diabetes
Inclusion
- Men and women aged 18-80 years
- Diagnosed with diabetes (of any type)
- No clinically established diabetic peripheral neuropathy at inclusion
Exclusion
- Alcohol or drug abuse within the last year (prior to inclusion)
- Chemotherapy (prior or within study period) or experimental medicine
- Severe vitamin deficiencies
- Inability to understand or comply with the examinations
- Planned or likely discontinuation of care at Aalborg University Hospital
- Known hematologic disorders resulting in a markedly reduced ability to stop small bleedings